INmune Bio schedules conference call to discuss Q2 2026 results

• INmune Bio scheduled a conference call on Aug. 6, 2026 at 4:30 p.m. ET to report Q2 results ended June 30, 2026.
• The call will include a corporate update; live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1769234&tp_key=7c277bcdb8.
• Replay available through Sept. 21, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310700PRIMZONEFULLFEED9800542) on July 31, 2026, and is solely responsible for the information contained therein.